OPPG |
OPRL1 |
Hodgkin and Reed-Sternberg cells |
||
Drug name: Neumega. A recombinant human IL11. The drug has been approved initially for the treatment of platelet deficiencies. A variety of clinical trials are currently being carried out for Crohn's disease and mucositis, colitis, rheumatoid arthritis, psoriasis.
... ... ... ... ... Subscribe to continue reading! ... ...
Content view restricted ! |